Colonic Mucosal Epigenome and Microbiome Development in Children and Adolescents

Journal of Immunology Research

Volumn 2016, Issue , 2016, Pages

  Harris, R Alan ^a   Shah, Rajesh ^a   Hollister, Emily B ^a,b   Tronstad, Rune Rose ^c,d   Hovdenak, Nils ^c   Szigeti, Reka ^a   Versalovic, James ^a,b   Kellermayer, Richard ^a,b,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e CHILDREN S NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGPAT1 PROTEIN; ARYLDIALKYLPHOSPHATASE 1; CHOLECYSTOKININ; CREB5 PROTEIN; DNA; ELTD1 PROTEIN; GJD2 PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; IL4R PROTEIN; KCNN3 PROTEIN; LAT2 PROTEIN; MLL3 PROTEIN; PCDHG4A PROTEIN; PTPRF PROTEIN; RNA 16S; SAA1 PROTEIN; SAA2 PROTEIN; SHANK2 PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 3; SP5 PROTEIN; SULF1 PROTEIN; SULT2B1 PROTEIN; TAGAP PROTEIN; TP53I11 PROTEIN; TRANSCRIPTION FACTOR PDX 1; TRIM15 PROTEIN; UNCLASSIFIED DRUG; KHDC3L PROTEIN, HUMAN; PROTEIN; SODIUM PROTON EXCHANGE PROTEIN; SODIUM-HYDROGEN EXCHANGER 3;

ADOLESCENT; ARTICLE; BACTEROIDES; BLAUTIA; CHILD; CHROMOSOME; COHORT ANALYSIS; COLON FLORA; COLON MUCOSA; COLORECTAL CANCER; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENETIC ASSOCIATION; GROUPS BY AGE; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; METAGENOMICS; MICROBIOME; PARABACTEROIDES; POSTNATAL DEVELOPMENT; PYROSEQUENCING; ROSEBURIA; STREPTOCOCCUS; ULCERATIVE COLITIS; CROHN DISEASE; CYTOLOGY; FEMALE; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; MALE; MICROBIOLOGY; MICROFLORA; NORMAL HUMAN; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CPG ISLANDS; CROHN DISEASE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INTESTINAL MUCOSA; MALE; MICROBIOTA; PROTEINS; RNA, RIBOSOMAL, 16S; SODIUM-HYDROGEN ANTIPORTER;

EID: 84960983840     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/9170162     Document Type: Article

References (34)

1. R. Kellermayer, "Epigenetics and the developmental origins of inflammatory bowel diseases," Canadian Journal of Gastroenterology, vol. 26, no. 12, pp. 909-915, 2012.
2. M. D. Kappelman, K. R. Moore, J. K. Allen, and S. F. Cook, "Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population," Digestive Diseases and Sciences, vol. 58, no. 2, pp. 519-525, 2013.
3. N. A. Molodecky, I. S. Soon, D. M. Rabi et al., "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review," Gastroenterology, vol. 142, no. 1, pp. 46-54, 2012.
4. J. Cosnes, C. Gower-Rousseau, P. Seksik, and A. Cortot, "Epidemiology and natural history of inflammatory bowel diseases," Gastroenterology, vol. 140, no. 6, pp. 1785-1794, 2011.
5. W. El-Matary, S. P. Moroz, and C. N. Bernstein, "Inflammatory bowel disease in children of Manitoba: 30 years' experience of a tertiary center," Journal of Pediatric Gastroenterology and Nutrition, vol. 59, no. 6, pp. 763-766, 2014.
6. B. Hope, R. Shahdadpuri, C. Dunne et al., "Rapid rise in incidence of Irish paediatric inflammatory bowel disease," Archives ofDisease in Childhood, vol. 97,no. 7, pp. 590-594, 2012.
7. W. A. Walters, Z. Xu, and R. Knight, "Meta-analyses of human gut microbes associated with obesity and IBD," FEBS Letters, vol. 588, no. 22, pp. 4223-4233, 2014.
8. E. I. Benchimol, D. R. Mack,A. Guttmann et al., "Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study," The American Journal of Gastroenterology, vol. 110, no. 4, pp. 553-563, 2015.
9. N. T. Ventham, N. A. Kennedy, E. R. Nimmo, and J. Satsangi, "Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics," Gastroenterology, vol. 145, no. 2, pp. 293-308, 2013.
10. M. Scarpa and E. Stylianou, "Epigenetics: concepts and relevance to IBD pathogenesis," Inflammatory Bowel Diseases, vol. 18, no. 10, pp. 1982-1996, 2012.
11. G. Koukos, C. Polytarchou, J. L. Kaplan et al., "A MicroRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium," Inflammatory Bowel Diseases, vol. 21, no. 5, pp. 996-1005, 2015.
12. C. A. Cooney, A. A. Dave, and G. L. Wolff, "Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring," Journal of Nutrition, vol. 132, supplement 8, pp. 2393S-2400S, 2002.
13. C. Faulk and D. C. Dolinoy, "Timing is everything: the when and how of environmentally induced changes in the epigenome of animals," Epigenetics, vol. 6, no. 7, pp. 791-797, 2011.
14. R. A. Waterland, R. Kellermayer, E. Laritsky et al., "Season of conception in rural gambia affectsDNA methylation at putative human metastable epialleles," PLoS Genetics, vol. 6, no. 12, Article ID e1001252, 2010.
15. B. Khulan,W. N. Cooper, B. M. Skinner et al., "Periconceptional maternal micronutrient supplementation is associated with widespread gender related changes in the epigenome: a study of a unique resource in the Gambia," Human Molecular Genetics, vol. 21, no. 9, pp. 2086-2101, 2012.
16. R. A. Harris, D. Nagy-Szakal, and R. Kellermayer, "Human metastable epiallele candidates link to common disorders," Epigenetics, vol. 8, no. 2, pp. 157-163, 2013.
17. R. Kellermayer, A. Balasa, W. Zhang et al., "Epigenetic maturation in colonic mucosa continues beyond infancy in mice," Human Molecular Genetics, vol. 19, no. 11, Article ID ddq095, pp. 2168-2176, 2010.
18. A. Peneau, G. Savoye, D. Turck et al., "Mortality and cancer in pediatric-onset inflammatory bowel disease: a populationbased study,"The American Journal of Gastroenterology, vol. 108, no. 10, pp. 1647-1653, 2013.
19. R. A. Harris, D. Nagy-Szakal, S. A. V. Mir et al., "DNA methylation-associated colonic mucosal immune and defense responses in treatmentnaüve pediatric ulcerative colitis," Epigenetics, vol. 9, no. 8, pp. 1131-1137, 2014.
20. R. A. Waterland and R. L. Jirtle, "Transposable elements: targets for early nutritional effects on epigenetic gene regulation," Molecular and Cellular Biology, vol. 23, no. 15, pp. 5293-5300, 2003.
21. M. J. Aryee, A. E. Jaffe,H. Corrada-Bravo et al., "Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays," Bioinformatics, vol. 30, no. 10, pp. 1363-1369, 2014.
22. R. Kellermayer, S. A. V. Mir, D. Nagy-Szakal et al., "Microbiota separation and C-reactive protein elevation in treatment-naüve pediatric granulomatous crohn disease," Journal of Pediatric Gastroenterology and Nutrition, vol. 55, no. 3, pp. 243-250, 2012.
23. M. Pelizzola and J. R. Ecker, "The DNA methylome," FEBS Letters, vol. 585, no. 13, pp. 1994-2000, 2011.
24. A. V. B. Granlund, A. Flatberg, A. E. Østvik et al., "Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis," PLoS ONE, vol. 8, no. 2, Article IDe56818, 2013.
25. J. Kraiczy, K. Nayak, A. Ross et al., "AssessingDNAmethylation in the developing human intestinal epithelium: potential link to inflammatory bowel disease," Mucosal Immunology, 2015.
26. T. Y. Fofanova, J. F. Petrosino, and R. Kellermayer, "Microbiome-epigenome interactions and the environmental origins of inflammatory bowel diseases," Journal of Pediatric Gastroenterology & Nutrition, vol. 62, no. 2, pp. 208-219, 2016.
27. P. S. Karatzas, G. J. Mantzaris, M. Safioleas, and M. Gazouli, "DNA methylation profile of genes involved in inflammation and autoimmunity in inflammatory bowel disease," Medicine, vol. 93, no. 28, article e309, 2014.
28. G. Fonseca-Camarillo and J. K. Yamamoto-Furusho, "Gene expression of solute carrier family 9 (sodium/hydrogen exchanger) 3, (SLC9A3) is downregulated in patients with ulcerative colitis," Inflammatory Bowel Diseases, vol. 18, no. 6, pp. 1197-1198, 2012.
29. C. B. Larmonier, D. Laubitz, F. M. Hill et al., "Reduced colonic microbial diversity is associated with colitis in NHE3-deficient mice,"TheAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 305, no. 10, pp. G667-G677, 2013.
30. S. O. Noor, K. Ridgway, L. Scovell et al., "Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota," BMC Gastroenterology, vol. 10, article 134, 2010.
31. D. A. Parry, C. V. Logan, B. E. Hayward et al., "Mutations causing familial biparental hydatidiform mole implicate C6orf221 as a possible regulator of genomic imprinting in the human oocyte," American Journal of Human Genetics, vol. 89, no. 3, pp. 451-458, 2011.
32. N. Hovdenak, "Ulcerative colitis, vitiligo and hydatidiform mole," Tidsskrift for den Norske Laegeforening, vol. 99, no. 23, pp. 1089-1099, 1979.
33. K. Machiels, M. Joossens, J. Sabino et al., "A decrease of the butyrate-producing species roseburia hominis and faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis," Gut, vol. 63, no. 8, pp. 1275-1283, 2014.
34. M. J. Silver, N. J. Kessler, B. J. Hennig et al., "Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment," Genome Biology, vol. 16, article 118, 2015.